Markets
News
Analysis
Tools
Learn
Stock
Score
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Talphera Cuts Costs and Speeds Trial
Talphera(NASDAQ:TLPH) reported second quarter 2025 results on August 14, 2025, highlighting accelerated clinical trial enrollment and a reduction in annual cash operating expense guidance to $16 million–$17 million for 2025. The company ended the quarter with $6.8 million in cash and reaffirmed its ...
The Motley Fool
Thu, Aug 14
Talphera TLPH Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DateThursday, Aug. 14, 2025 at 4:30...
The Motley Fool
Thu, Aug 14
Tyra Biosciences Narrows Loss in Q2
Key PointsGAAP loss per share of $(0.47) for Q2 2025 was narrower than the $(0.53) analysts had expected, despite an ongoing absence of revenue.Research and development expenses (GAAP) increased 35.0% year over year, supporting clinical trial progress.Clinical pipeline hit milestones in bladder canc...
The Motley Fool
Thu, Aug 14
Reviva Pharmaceuticals Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Reviva Pharmaceuticals Holdings Inc RVPH.OQ reported a quarterly adjusted loss of 12 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -26 cents. The mean expectation of six analysts for the quarter was for a loss of 11 cents p...
Reuters
Thu, Aug 14
bioAffinity Misses Q2 Revenue Target
Key PointsGAAP revenue of $1.3 million for Q2 2025 missed the consensus estimate of $1.51 million and declined 45.8% from the second quarter of the prior year.GAAP earnings per share (EPS) were $(0.17) for Q2 2025, underperforming the analyst expectation of $(0.10) and but narrower than the $(0.19) ...
The Motley Fool
Thu, Aug 14
Arcadia Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Arcadia Biosciences Inc RKDA.OQ reported quarterly adjusted earnings of 2 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 78 cents. The lone analyst forecast for the quarter was for a loss of 79 cents per share. Revenue rose 1...
Reuters
Thu, Aug 14
Sandisk Reports 8 Percent Revenue Gain
Key PointsRevenue (GAAP) rose 8% year over year in Q4 FY2025, exceeding prior guidance and driven by strong cloud segment growth, with cloud revenue up 103% year-over-year to $197 million in Q3.Gross margin (GAAP) improved sequentially, but at 26.2% (GAAP) remains almost 10 percentage points below t...
The Motley Fool
Thu, Aug 14
Genasys Backlog Hits 61 Million in Q3
Genasys (NASDAQ:GNSS) reported fiscal 3Q2025 results on August 14, 2025, with revenues rising 38% year over year to $9.9 million (GAAP) on strong contributions from Puerto Rico. Hardware sales drove growth. Gross margins fell to 26.3% due to an unfavorable mix, and management announced $2.5 million ...
The Motley Fool
Thu, Aug 14
Reading Revenue Jumps 29% in Fiscal Q2
Key PointsGAAP revenue rose 29.0% to $60.4 million in Q2 2025, surpassing expectations by $1.0 million.GAAP diluted EPS loss of $(0.12) missed estimates but improved sharply year over year.Operating income reached $2.9 million, reversing last year’s GAAP loss.These 10 stocks could mint the next wave...
The Motley Fool
Thu, Aug 14
Unusual Machines Sales Jump 51%
Key PointsRecord revenue of $2.12 million (GAAP) for Q2 2025, up 51% year over year.But GAAP net loss increased due to stock compensation expense.Cash balance was $38.93 million as of June 30, 2025, with additional capital raised after quarter-end, while operating expenses rose sharply and diluted s...
The Motley Fool
Thu, Aug 14
Co-Diagnostics CODX Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DateThursday, August 14, 2025 at 4:...
The Motley Fool
Thu, Aug 14
P3 Health Partners Posts Q2 Revenue Drop
Key PointsNon-GAAP earnings per share and GAAP revenue both missed analyst estimates, with a deeper-than-expected adjusted EBITDA loss (non-GAAP).Average at-risk membership declined 9% year over year, continuing a trend of network rationalization and top-line pressure.but the company's consolidated ...
The Motley Fool
Thu, Aug 14
Fortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc FBIO.OQ reported a quarterly adjusted loss of 50 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -73 cents. The mean expectation of two analysts for the quarter was for a loss of 36 cents per share. Wall ...
Reuters
Thu, Aug 14
Stock Market Today: Opendoor Soars 26% on Meme Rally
Shares of Opendoor Technologies (NASDAQ: OPEN) surged 25.62% on Thursday, closing at $3.04 as volume spiked to nearly 316 million shares -- roughly 66% above the 3-month average. The stock became a top target for retail traders following increased chatter on social platforms and signs of elevated sh...
The Motley Fool
Thu, Aug 14
Elutia Posts Narrower Loss in Fiscal Q2
Key PointsGAAP EPS loss narrowed significantly year over year in Q2 2025, but operating losses increased due to higher litigation expenses.GAAP revenue was essentially flat in Q2 2025 compared to Q2 2024, as strong EluPro adoption offset declines in SimpliDerm and Cardiovascular products.Adjusted gr...
The Motley Fool
Thu, Aug 14
Dragonfly (DFLI) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DATEThursday, August 14, 2025 at 4:...
The Motley Fool
Thu, Aug 14
Celcuity Expenses Jump 81 Percent
Key PointsNon-GAAP earnings per share (EPS) of ($0.93) in Q2 2025 missed analyst estimates by 5.7%.Total operating expenses increased 81.1% to $44.0 million in Q2 2025, up from $24.3 million in Q2 2024.Gedatolisib reduced the risk of progression or death by 76% in the Phase 3 VIKTORIA-1 breast cance...
The Motley Fool
Thu, Aug 14
Why Cisco Systems Stock Sank on Thursday
Key PointsThe networking company published the final quarterly earnings report for its fiscal 2025.These showed decent gains in revenue and profitability, but investors were hoping for more.10 stocks we like better than Cisco Systems › Cisco Systems (NASDAQ: CSCO) wasn't a particularly popular tech ...
The Motley Fool
Thu, Aug 14
Tivic Health (TIVC) Q2 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DateAug. 14, 2025 at 4:30 p.m. ETCa...
The Motley Fool
Thu, Aug 14
Nano Nuclear Energy Inc reports results for the quarter ended June 30 - Earnings Summary
Nano Nuclear Energy Inc NNE.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended June 30. The mean expectation of three analysts for the quarter was for a loss of 20 cents per share. Wall Street expected results to range from -40 cents to -7 cents per share.Reported r...
Reuters
Thu, Aug 14
1
...
363
364
365
365
/
4127
366
367
...
4127
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up